Can apixaban prevent venous thromboembolism better than rivaroxaban?

Can apixaban prevent venous thromboembolism better than rivaroxaban?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet. Haematology 2019-04, Vol.6 (4), p.e180-e180
Hauptverfasser: Akbashev, Mikhail, Adhyaru, Bhavin, Allen, Arthur
Format: Artikel
Sprache:eng
Schlagworte:
Humans
Pyrazoles
Pyridones
Retrospective Studies
Rivaroxaban
Venous Thromboembolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e180
container_issue 4
container_start_page e180
container_title The Lancet. Haematology
container_volume 6
creator Akbashev, Mikhail
Adhyaru, Bhavin
Allen, Arthur
description
doi_str_mv 10.1016/S2352-3026(19)30053-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2200785012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352302619300535</els_id><sourcerecordid>2200785012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-71aef4fa00014092a6ea2d91b911d0910d3f8f6b69ac313209ec42964ca949e13</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EolXpJ4CyLIvA2E6celWh8pQqsQDWluNMhFFe2GkFf4_TloodC9uj0b0z14eQcwpXFKi4fmE8ZTEHJmZUXnKAlMfpERkf2sd_6hGZev8BAJRnIhXylIw4SCYgk2Nyu9RNpDv7pfNQdA432PRRuNq1j_p319Z5i-FU1tdRjn2PLrSD1NmNdu3WtjgjJ6WuPE7374S83d-9Lh_j1fPD0_JmFRtOeR9nVGOZlHqIkoQEWqBmhaS5pLQASaHg5bwUuZB6MDCQaBImRWK0TCRSPiGz3dzOtZ9r9L2qrTdYVbrBkFcxBpDNU6AsSNOd1LjWe4el6pyttftWFNTAUG0ZqgGQolJtGao0-C72K9Z5jcXB9UssCBY7AYaPbiw65Y3FxmBhHZpeFa39Z8UPlpp_8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2200785012</pqid></control><display><type>article</type><title>Can apixaban prevent venous thromboembolism better than rivaroxaban?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Akbashev, Mikhail ; Adhyaru, Bhavin ; Allen, Arthur</creator><creatorcontrib>Akbashev, Mikhail ; Adhyaru, Bhavin ; Allen, Arthur</creatorcontrib><identifier>ISSN: 2352-3026</identifier><identifier>EISSN: 2352-3026</identifier><identifier>DOI: 10.1016/S2352-3026(19)30053-5</identifier><identifier>PMID: 30926079</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Humans ; Pyrazoles ; Pyridones ; Retrospective Studies ; Rivaroxaban ; Venous Thromboembolism</subject><ispartof>The Lancet. Haematology, 2019-04, Vol.6 (4), p.e180-e180</ispartof><rights>2019 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c313t-71aef4fa00014092a6ea2d91b911d0910d3f8f6b69ac313209ec42964ca949e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30926079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akbashev, Mikhail</creatorcontrib><creatorcontrib>Adhyaru, Bhavin</creatorcontrib><creatorcontrib>Allen, Arthur</creatorcontrib><title>Can apixaban prevent venous thromboembolism better than rivaroxaban?</title><title>The Lancet. Haematology</title><addtitle>Lancet Haematol</addtitle><subject>Humans</subject><subject>Pyrazoles</subject><subject>Pyridones</subject><subject>Retrospective Studies</subject><subject>Rivaroxaban</subject><subject>Venous Thromboembolism</subject><issn>2352-3026</issn><issn>2352-3026</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EolXpJ4CyLIvA2E6celWh8pQqsQDWluNMhFFe2GkFf4_TloodC9uj0b0z14eQcwpXFKi4fmE8ZTEHJmZUXnKAlMfpERkf2sd_6hGZev8BAJRnIhXylIw4SCYgk2Nyu9RNpDv7pfNQdA432PRRuNq1j_p319Z5i-FU1tdRjn2PLrSD1NmNdu3WtjgjJ6WuPE7374S83d-9Lh_j1fPD0_JmFRtOeR9nVGOZlHqIkoQEWqBmhaS5pLQASaHg5bwUuZB6MDCQaBImRWK0TCRSPiGz3dzOtZ9r9L2qrTdYVbrBkFcxBpDNU6AsSNOd1LjWe4el6pyttftWFNTAUG0ZqgGQolJtGao0-C72K9Z5jcXB9UssCBY7AYaPbiw65Y3FxmBhHZpeFa39Z8UPlpp_8g</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Akbashev, Mikhail</creator><creator>Adhyaru, Bhavin</creator><creator>Allen, Arthur</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201904</creationdate><title>Can apixaban prevent venous thromboembolism better than rivaroxaban?</title><author>Akbashev, Mikhail ; Adhyaru, Bhavin ; Allen, Arthur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-71aef4fa00014092a6ea2d91b911d0910d3f8f6b69ac313209ec42964ca949e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Humans</topic><topic>Pyrazoles</topic><topic>Pyridones</topic><topic>Retrospective Studies</topic><topic>Rivaroxaban</topic><topic>Venous Thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akbashev, Mikhail</creatorcontrib><creatorcontrib>Adhyaru, Bhavin</creatorcontrib><creatorcontrib>Allen, Arthur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet. Haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akbashev, Mikhail</au><au>Adhyaru, Bhavin</au><au>Allen, Arthur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can apixaban prevent venous thromboembolism better than rivaroxaban?</atitle><jtitle>The Lancet. Haematology</jtitle><addtitle>Lancet Haematol</addtitle><date>2019-04</date><risdate>2019</risdate><volume>6</volume><issue>4</issue><spage>e180</spage><epage>e180</epage><pages>e180-e180</pages><issn>2352-3026</issn><eissn>2352-3026</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30926079</pmid><doi>10.1016/S2352-3026(19)30053-5</doi></addata></record>
fulltext fulltext
identifier ISSN: 2352-3026
ispartof The Lancet. Haematology, 2019-04, Vol.6 (4), p.e180-e180
issn 2352-3026
2352-3026
language eng
recordid cdi_proquest_miscellaneous_2200785012
source MEDLINE; Alma/SFX Local Collection
subjects Humans
Pyrazoles
Pyridones
Retrospective Studies
Rivaroxaban
Venous Thromboembolism
title Can apixaban prevent venous thromboembolism better than rivaroxaban?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T23%3A43%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20apixaban%20prevent%20venous%20thromboembolism%20better%20than%20rivaroxaban?&rft.jtitle=The%20Lancet.%20Haematology&rft.au=Akbashev,%20Mikhail&rft.date=2019-04&rft.volume=6&rft.issue=4&rft.spage=e180&rft.epage=e180&rft.pages=e180-e180&rft.issn=2352-3026&rft.eissn=2352-3026&rft_id=info:doi/10.1016/S2352-3026(19)30053-5&rft_dat=%3Cproquest_cross%3E2200785012%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2200785012&rft_id=info:pmid/30926079&rft_els_id=S2352302619300535&rfr_iscdi=true